Rang	Name	Position
1	Mr. David P. Hochman	Founder, Chairman of the Board of Directors & CEO
2	Mr. Darren R. Sherman	Founder, President, COO & Director
3	Mr. Andrew Lawrence Taylor M.B.A.	Chief Financial Officer
4	Mr. William Reed Little	Executive Vice President of Corporate Development & Strategy
5	Ms. Lisa Daniels	Vice President of Human Resources
6	Dr. Yuval Hay Mika D.Sc, Ph.D.	GM & CTO of Bioelectronic Therapies
7	Dr. Hans-Peter Stoll M.D., Ph.D.	Senior VP & Medical Director
8	Dr. Avraham Matityahu Fischer M.D.	Senior Vice President of Medical Affairs & Innovation
9	Mr. Bob Laughner	Senior Vice President of Regulatory & Quality
10	Mr. Juan Lorenzo	Senior Vice President of Product Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	RTW INVESTMENTS, LLC	15,90%	58,20 Mio. USD
2	Perceptive Advisors LLC	8,38%	30,68 Mio. USD
3	BlackRock Inc	4,18%	15,29 Mio. USD
4	Vanguard Capital Management, LLC	3,37%	12,32 Mio. USD
5	Geode Capital Management, LLC	1,68%	6,14 Mio. USD
6	Alyeska Investment Group, L.P.	1,66%	6,09 Mio. USD
7	Propel Bio Management LLC	1,49%	5,46 Mio. USD
8	UBS Asset Mgmt Americas Inc	1,07%	3,91 Mio. USD
9	State Street Corp	0,86%	3,14 Mio. USD
10	Rice Hall James & Associates, LLC	0,71%	2,58 Mio. USD
11	Charles Schwab Investment Management Inc	0,58%	2,13 Mio. USD
12	Northern Trust Corp	0,57%	2,09 Mio. USD
13	UBS Group AG	0,54%	1,98 Mio. USD
14	Vanguard Fiduciary Trust Co	0,49%	1,78 Mio. USD
15	Vanguard Portfolio Management, LLC	0,46%	1,68 Mio. USD
16	Knott David M Jr	0,42%	1,55 Mio. USD
17	Flat Footed LLC	0,42%	1,53 Mio. USD
18	Simplify Asset Management Inc.	0,37%	1,34 Mio. USD
19	683 Capital Management LLC	0,31%	1,13 Mio. USD
20	The Goldman Sachs Group Inc	0,30%	1,09 Mio. USD